Antibody constructs and methods of treating cancer
US11623953B2 · kind B2 · utility
0Cited by
10References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 27, 2018 |
| Grant date | Apr 11, 2023 |
| Priority date | — |
| Expiry date | Feb 27, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are antibodies and related polypeptides that bind specifically to CEACAM6. The antibodies and/or polypeptides can be configured as bispecific T cell engagers. The antibodies and/or polypeptides can also be configured as chimeric antigen receptors. Also provided are methods of detection and treatment of cancer, for example, pancreatic cancer, using the antibodies and related polypeptides herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.